@article{25ee34a2a3bf440487626f0b255ec1f9,
title = "Taming the chronic kidney disease epidemic: A global view of surveillance efforts",
abstract = "Chronic kidney disease is now recognized to be a worldwide problem associated with significant morbidity and mortality and there is a steep increase in the number of patients reaching end-stage renal disease. In many parts of the world, the disease affects younger people without diabetes or hypertension. The costs to family and society can be enormous. Early recognition of CKD may help prevent disease progression and the subsequent decline in health and longevity. Surveillance programs for early CKD detection are beginning to be implemented in a few countries. In this article, we will focus on the challenges and successes of these programs with the hope that their eventual and widespread use will reduce the complications, deaths, disabilities, and economic burdens associated with CKD worldwide.",
keywords = "chronic kidney disease, epidemiology, surveillance",
author = "Jai Radhakrishnan and Giuseppe Remuzzi and Rajiv Saran and Williams, {Desmond E.} and Nilka Rios-Burrows and Neil Powe and Katharina Br{\"u}ck and Christoph Wanner and Stel, {Vianda S.} and Venuthurupalli, {Sree K.} and Hoy, {Wendy E.} and Healy, {Helen G.} and Anne Salisbury and Fassett, {Robert G.} and Donal O'Donoghue and Paul Roderick and Seiichi Matsuo and Akira Hishida and Enyu Imai and Satoshi Iimuro",
note = "Funding Information: The CKD.QLD registry is supported by Amgen, Roche, NHMRC Australia (Australian Fellowship—Wendy Hoy), the Colonial Foundation of Australia (an untied grant to Wendy Hoy), and Queensland Health in-kind. Funding Information: Significant challenges to the registry include the time required to gain informed consent and the different degree of detail of captured data among sites. Data capture will be simplified with unrolling of the Queensland Health{\textquoteright}s electronic health record system. The biggest challenge, however, is that of ongoing funding to support registry activities. Currently, the CKD.QLD registry is funded by Queensland Health (in-kind), Amgen, Roche, Australia{\textquoteright}s National Health and Medical Research Council, and the Colonial Foundation of Australia. We expect the translational outcomes generated through the registry to attract long-term funding from Queensland Health, the chief potential benefactor. Funding Information: The research leading to these results has received funding from QUEST and the European Community{\textquoteright}s Seventh Framework Programme under grant agreement number HEALTH-F2-2009-241544 (SysKID). ",
year = "2014",
month = aug,
doi = "10.1038/ki.2014.190",
language = "English (US)",
volume = "86",
pages = "246--250",
journal = "Kidney international",
issn = "0085-2538",
publisher = "Elsevier B.V.",
number = "2",
}